VLST, AnaptsyBio Developing Antibody Therapeutics for Autoimmune, Inflammatory Disorders

VLST, which uses an approach combining proteomics and bioinformatics to develop biologic therapeutics, would commercialize any product developed from the collaboration.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.